Search - tctmd.com

Displaying 981 - 1000 of 3032

Sort: Relevancy | Date

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Daily News

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

Todd Neale

January 21, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

FDA: Some Stryker Defibrillators Require Fix for Failure to Deliver Shock

Todd Neale

January 13, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2019

Shelley Wood

December 31, 2019

News Daily News

FDA Approves Two Generic Versions of Apixaban

Todd Neale

December 23, 2019

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

L.A. McKeown

December 17, 2019

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

Advertisement

European Regulators Approve First Transcatheter MV Replacement Device

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

FDA’s First Take on New Paclitaxel Concerns in CLI

Venous Stents: Long-term Follow-up Plus a New Contender

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

FDA: Some Stryker Defibrillators Require Fix for Failure to Deliver Shock

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

The Biggest News of 2019: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for December 2019

FDA Approves Two Generic Versions of Apixaban

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

FDA Approves Icosapent Ethyl for Reducing CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content